PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,954 | +629.4% | 177,125 | +1108.7% | 0.03% | +833.3% |
| Q2 2023 | $405 | -58.8% | 14,654 | -83.7% | 0.00% | -78.6% |
| Q4 2022 | $983 | -99.9% | 90,107 | -17.2% | 0.01% | +16.7% |
| Q3 2022 | $918,000 | +4.4% | 108,876 | -2.0% | 0.01% | +9.1% |
| Q2 2022 | $879,000 | +177.3% | 111,126 | +607.8% | 0.01% | +266.7% |
| Q4 2020 | $317,000 | -16.4% | 15,701 | -47.9% | 0.00% | -89.3% |
| Q1 2019 | $379,000 | +294.8% | 30,119 | +112.1% | 0.03% | +300.0% |
| Q4 2018 | $96,000 | – | 14,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |